RESUMO
Gingival overgrowth is, among other things, a side effect of the administration of dihydropyridine antihypertensives, generally associated with irritant factors of marginal periodontium. This case refers to a patient, female, who developed a large gingival enlargement that has a combined etiology: the systemic medication with lercanidipina and the presence of dental bridges, which are incorrectly adjusted to the dental cervix. The treatment for this case, involved a complex local treatment (antimicrobial, surgical, endodontic and prosthetic) and the collaboration with a specialist cardiologist. Maintaining the normal gingival parameters in time depends on the possibility of changing the antihypertensive medication, the accuracy of the new dental bridges and the periodic monitoring of the patient.
Assuntos
Bloqueadores dos Canais de Cálcio/efeitos adversos , Prótese Parcial/efeitos adversos , Crescimento Excessivo da Gengiva/etiologia , Crescimento Excessivo da Gengiva/patologia , Hipertensão/tratamento farmacológico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Profilaxia Dentária , Di-Hidropiridinas/efeitos adversos , Feminino , Crescimento Excessivo da Gengiva/induzido quimicamente , Crescimento Excessivo da Gengiva/cirurgia , Gengivectomia , Humanos , Pessoa de Meia-IdadeRESUMO
Systemic diseases are of major importance in terms of prosthetic restorations supported by dental implants in healthy compromised patients. Each treatment stage from conception of the treatment plan to the long-term monitoring is under the necessity of the interdisciplinary approach to the underlying disease.
